Guided Therapeutics (GTHP) Cash & Equivalents (2010 - 2026)
Guided Therapeutics (GTHP) reported Cash & Equivalents of $12,000 for Q2 2026, down 93.5% from $185,000 a year earlier and down 96.7% from the prior quarter.
Powered by 
Analysis
Guided Therapeutics (GTHP) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Guided Therapeutics posted Cash & Equivalents of $63,000, down 83.8% from FY2024.
- Cash & Equivalents has declined for three consecutive years, with a five-year compound annual growth rate of -19.1% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $388,000 in FY2024 (-34.3%), $591,000 in FY2023 (-74.4%), $2.31 million in FY2022 (+259.7%) and $643,000 in FY2021 (+253.3%).
- The Q2 2026 figure ranks as the lowest quarterly Cash & Equivalents since Q1 2019.
- Year over year, Cash & Equivalents gained in 1 of the last eight quarters, with an average decline of 28.3%.
- The high point for year-over-year Cash & Equivalents in five years was Q3 2022 (growth of 398.5%); the low point was Q2 2026 (a decline of 93.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $369,000 (Q1 2026), $63,000 (Q4 2025) and $87,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 242.18 Bn | 221.33 Bn | 4.88 Bn | 4.06 Bn |
| 2 | Abbott Laboratories | 168.71 Bn | 139.79 Bn | 7.27 Bn | 5.10 Bn |
| 3 | Danaher | 150.46 Bn | 134.27 Bn | 3.61 Bn | 4.35 Bn |
| 4 | Intuitive Surgical | 138.71 Bn | 118.26 Bn | 1.96 Bn | 2.76 Bn |
| 5 | Medtronic | 110.54 Bn | 76.41 Bn | 6.34 Bn | 1.69 Bn |
| 6 | Stryker | 105.66 Bn | 91.78 Bn | 4.50 Bn | 3.39 Bn |
| 7 | Boston Scientific | 61.74 Bn | 56.75 Bn | 3.85 Bn | 539.00 Mn |
| 8 | Edwards Lifesciences | 49.09 Bn | 33.21 Bn | 1.35 Bn | 2.91 Bn |
| 9 | Becton Dickinson | 48.16 Bn | 45.31 Bn | 2.32 Bn | 708.00 Mn |
| 10 | Guided Therapeutics | 21.24 Mn | 20.71 Mn | - | 12,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12,000.00 |
| Mar 31, 2026 | 369,000.00 |
| Dec 31, 2025 | 63,000.00 |
| Sep 30, 2025 | 87,000.00 |
| Jun 30, 2025 | 185,000.00 |
| Mar 31, 2025 | 115,000.00 |
| Dec 31, 2024 | 388,000.00 |
| Sep 30, 2024 | 194,000.00 |
| Jun 30, 2024 | 275,000.00 |
| Mar 31, 2024 | 445,000.00 |
| Dec 31, 2023 | 591,000.00 |
| Sep 30, 2023 | 731,000.00 |
| Jun 30, 2023 | 1.36 Mn |
| Mar 31, 2023 | 1.84 Mn |
| Dec 31, 2022 | 2.31 Mn |
| Sep 30, 2022 | 2.70 Mn |
| Jun 30, 2022 | 446,000.00 |
| Mar 31, 2022 | 725,000.00 |
| Dec 31, 2021 | 643,000.00 |
| Sep 30, 2021 | 541,000.00 |
API Access
Guided Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GTHP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "GTHP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GTHP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();